Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

AGM

RVXoldtimer

Oct 08, 2020 01:44AM

Bear

Telepanel

Oct 09, 2020 06:01AM

fuzzyjr

Rank: Vice President [?]

Points: 5268 [?]

Votes: 36 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Bear

in response to

Bear

Telepanel

posted on Oct 09, 2020 11:33AM

1) Yes they have.Need more patients tho - bigger longer trial(s)

2) Yes but we will take colab with BMS, now we have 3 or 4 (if include Newsoara), so DM creating competitive tension, next best thing to outright sale

3) Yes, like rvx anything is possible.

2 Recommendations

Re: Bear - Zenith valuation today, my guess $500M tops or around $4/share. Who's willing to take $4 now?

Payzone

Oct 09, 2020 04:05PM

Re: Bear

BearDownAZ

Oct 09, 2020 05:23PM

Re: Bear - Zenith valuation today, my guess $500M tops or around $4/share. Who's willing to take $4 now?